What is 13F confidential treatment? Delayed disclosure
13F confidential treatment is the process by which an institutional investment manager asks the US Securities and Exchange Commission (SEC) to omit certain Section 13(f) holdings from its public Form 13F while the request is reviewed. It is why a 13F reader sometimes sees a notice that information has been withheld, and why a later amendment can add positions that were not in the original report. This guide explains what 13F confidential treatment is and how to spot it. It is not investment advice.
Definition
13F confidential treatment
is a request a manager makes to the SEC to omit certain Section 13(f) holdings from a public Form 13F while the request is under review. If granted, the positions are held back for a period, then disclosed in a later amendment. The public report notes that information has been omitted. Source: SEC.
Why would a manager ask for confidential treatment?
A manager building or unwinding a large position may not want that program visible while it is still under way, because disclosure could move the price against the trade. The manager can ask the SEC to keep those specific holdings out of the public 13F for a time. The request must be justified to the SEC, and it is the SEC that grants, denies, or lets the treatment lapse.
How can you tell a 13F held something back?
When the confidential treatment option is used, the public Form 13F-HR or 13F-HR/A carries a notice that confidential information has been omitted from the public report. That is the reader's flag. When the treatment period ends, or the request is denied, the manager files an amendment that adds the previously withheld positions, so the full picture appears later than the original quarter's report.
Omitted, then disclosed later
Confidential 13F holdings are withheld from the public report during review, then added in a later amendment
Source: SEC
What this means for reading a 13F
A 13F is already a backward-looking snapshot, filed within 45 days of quarter-end. Confidential treatment adds a second lag: some positions can surface only in a later amendment. For the notice-versus-holdings distinction, see 13F-HR vs 13F-NT, and for how a 13F compares with a fast beneficial-ownership disclosure, see 13F vs 13D.
Every Form 13F and its amendments sit on the SEC's EDGAR system, which you can search for free. Flock reads disclosure filings and keeps each one dated and linked to its source, so you can compare an original 13F with a later amendment in one step. What any of it means for your money is your call to make.
Frequently asked questions
What is 13F confidential treatment?
13F confidential treatment is a request an institutional manager makes to the SEC to omit certain Section 13(f) holdings from the public Form 13F while the request is under review. If granted, those positions are held back from the public report for a period and disclosed later. Source: SEC.
Why would a manager request it?
A manager may seek confidential treatment when disclosing a position while it is still building or unwinding it could reveal an ongoing program. The manager must justify the request to the SEC. The public Form 13F then notes that information has been omitted until the request is resolved. Source: SEC.
How do you know a 13F omitted holdings?
When the confidential treatment option is used, the public Form 13F-HR or 13F-HR/A shows a notice that confidential information has been omitted from the public report. Once treatment ends or is denied, the manager files an amendment adding the previously withheld positions. Source: SEC.
Where can I read the filings?
Every Form 13F, including amendments that add previously confidential holdings, is filed on the SEC's EDGAR system and is free to read. Search by the manager's name and compare the original report with any later amendment. Source: SEC EDGAR.
Flock tracks these filings, sourced, dated, and linked back to the original. See what smart-money entities disclosed, without the guesswork about what it means.
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.